/PRNewswire/ According to Coherent Market Insights, The global cancer biopsy market was valued at US$ 25.61Billion in 2023 and is forecast to reach a value.
/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ:.